pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
amoxicillin + vonoprazan fumarate
Voquezna Dual Pak (amoxicillin + vonoprazan fumarate)
Helicobacter pylori Infections
$PHATPhathom Pharmaceuticals, Inc.
6 catalysts
Marketed
axitinib SR
AXPAXLI (axitinib)
Wet (Neovascular / Exudative) Macular Degeneration
Vascular endothelial growth factor receptor
$OCULOCULAR THERAPEUTIX, INC
1 catalysts
Marketed
(doravirine + lamivudine + tenofovir disoproxil fumarate)
Delstrigo ((doravirine + lamivudine + tenofovir disoproxil fumarate))
← prev
page 30 of 231
next →
131
Pain89
Neurology1
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Merck Sharp & Dohme Corp (Inactive)
7 catalysts
Marketed
doravirine
Pifeltro (doravirine)
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Merck Sharp & Dohme Corp (Inactive)
6 catalysts
Marketed
JUBBONTI
JUBBONTI (DENOSUMAB-BBDZ)
Sandoz Inc
3 catalysts
Marketed
OSENVELT
OSENVELT (DENOSUMAB-BMWO)
Celltrion Inc
3 catalysts
Marketed
AUKELSO
AUKELSO (DENOSUMAB-KYQQ)
$HCWBHCW Biologics Inc.
2 catalysts
Marketed
BILPREVDA
BILPREVDA (DENOSUMAB-NXXP)
Shanghai Henlius Biotech Inc
2 catalysts
Marketed
CONEXXENCE
CONEXXENCE (DENOSUMAB-BNHT)
Fresenius Kabi USA LLC
2 catalysts
Marketed
ENOBY
ENOBY (DENOSUMAB-QBDE)
$LBRXLB PHARMACEUTICALS INC
2 catalysts
Marketed
denosumab biosimilar
Jubereq (denosumab-dssb)
Post Menopausal Osteoporosis
Luye Pharma Group Ltd
2 catalysts
Marketed
OSVYRTI
OSVYRTI (denosumab-desu)
$ABVCABVC BIOPHARMA, INC.
1 catalysts
Marketed
DEXTROAMPHETAMINE SULFATE
DEXTROAMPHETAMINE SULFATE (DEXTROAMPHETAMINE SULFATE)
Attention Deficit Hyperactivity Disorder (ADHD)
Sunrise Pharmaceutical Inc
8 catalysts
Marketed
infliximab biosimilar
Renflexis (infliximab-abda)
Pulmonary Sarcoidosis
Tumor necrosis factor
Xentria Inc
6 catalysts
Marketed
lebrikizumab
Ebglyss (lebrikizumab)
Atopic Dermatitis (Atopic Eczema)
Lilly USA LLC
3 catalysts
Marketed
glofitamab
Columvi (glofitamab-gxbm)
Mantle Cell Lymphoma
B-lymphocyte antigen CD20T cell surface glycoprotein CD3
F. Hoffmann-La Roche Ltd
3 catalysts
Marketed
LOMUSTINE
LOMUSTINE (LOMUSTINE)
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma)
Carnegie Pharmaceuticals LLC
1 catalysts
Marketed
Renvela
Renvela (sevelamer carbonate)
Hyperphosphatemia In Chronic Kidney Disease
Sanofi-Aventis US LLC
1 catalysts
Marketed
(empagliflozin + linagliptin)
Glyxambi ((empagliflozin + linagliptin))
Type 2 Diabetes
Boehringer Ingelheim Corp
21 catalysts
Marketed
(empagliflozin + metformin hydrochloride ER)
Synjardy XR ((empagliflozin + metformin hydrochloride))
Type 2 Diabetes
Boehringer Ingelheim Corp
15 catalysts
Marketed
ANASTROZOLE
ANASTROZOLE (ANASTROZOLE)
Hormone Sensitive Breast Cancer
Stason Pharmaceuticals Inc
11 catalysts
Marketed
LEFLUNOMIDE
LEFLUNOMIDE (LEFLUNOMIDE)
Rheumatoid Arthritis
Abhai Inc
8 catalysts
Marketed
(empagliflozin + linagliptin + metformin hydrochloride) ER
Trijardy XR ((empagliflozin + linagliptin + metformin hydrochloride))
Type 2 Diabetes
Boehringer Ingelheim Corp
7 catalysts
Marketed
NEOSTIGMINE METHYLSULFATE
NEOSTIGMINE METHYLSULFATE (NEOSTIGMINE METHYLSULFATE)
Acetylcholinesterase
$AMPHAmphastar Pharmaceuticals, Inc.
3 catalysts
Marketed
revumenib citrate
Revuforj (revumenib citrate)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
$SNDXSyndax Pharmaceuticals Inc
2 catalysts
Marketed
DESIPRAMINE HYDROCHLORIDE
DESIPRAMINE HYDROCHLORIDE (DESIPRAMINE HYDROCHLORIDE)
Depression
Validus Pharmaceuticals LLC
7 catalysts
Marketed
mirikizumab
Omvoh (mirikizumab-mrkz)
Ulcerative Colitis
Interleukin-23
Eli Lilly and Co
5 catalysts
Marketed
belantamab mafodotin
Blenrep (belantamab mafodotin-blmf)
Refractory Multiple Myeloma
GlaxoSmithKline LLC
1 catalysts
Marketed
clonidine hydrochloride
Clonidine Hydrochloride (clonidine hydrochloride)
Hypertension
Frontida Biopharm Inc
1 catalysts
Marketed
ESMOLOL HYDROCHLORIDE
ESMOLOL HYDROCHLORIDE (ESMOLOL HYDROCHLORIDE)
Infantile Hemangiomas
Arkayli Biopharma Inc
33 catalysts